{
    "clinical_study": {
        "@rank": "89111", 
        "acronym": "INSPIRE-ELR", 
        "arm_group": {
            "arm_group_label": "External Loop Recorder", 
            "arm_group_type": "Other", 
            "description": "This is a non-randomized study. All the patients will be enrolled will received the ELR system."
        }, 
        "brief_summary": {
            "textblock": "The purpose of the INSPIRE-ELR study is to characterize arrhythmias in post MI low EF (\u226435%)\n      patients in the acute phase (at discharge from hospital after index MI) and chronic phase\n      (at 8-10 weeks after index MI) and to correlate with patients at high risk of all-cause\n      mortality or sudden cardiac death (SCD) at 1 year."
        }, 
        "brief_title": "IdeNtifying High riSk Patients Post Myocardial Infarction With REduced Left Ventricular Function Using External Loop Recorders (INSPIRE-ELR Study)", 
        "completion_date": {
            "#text": "December 2017", 
            "@type": "Anticipated"
        }, 
        "condition": "Post Myocardial Infarction Patients With Ejection Fraction Less Than or Equal to 35%", 
        "condition_browse": {
            "mesh_term": [
                "Infarction", 
                "Myocardial Infarction"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Patients must provide written informed consent/data release consent to participate in\n             the study.\n\n          2. Acute Myocardial Infarction (STEMI or non-STEMI) within the last 10 days based on\n             ESC/ACC/AHA/WHF criteria (Thygesen, 2012) matching the following criteria:\n\n             Rise and/or fall of cardiac biomarker values [preferably cardiac troponin (cTn)] with\n             at least one value above the 99th percentile upper reference limit (URL) and with at\n             least one of the following:\n\n               1. Symptoms of ischaemia.\n\n               2. New or presumed new significant ST-segment-T wave (ST-T) changes or new left\n                  bundle branch block (LBBB).\n\n               3. Development of pathological Q waves in the ECG.\n\n               4. Imaging evidence of new loss of viable myocardium or new regional wall motion\n                  abnormality.\n\n               5. Identification of an intracoronary thrombus by angiography.\n\n          3. LVEF \u226435% as measured by echocardiography (Simpson's method, biplane) one day before\n             or on the day of hospital discharge\n\n        Exclusion Criteria:\n\n          1. Patients who cannot be discharged from the hospital within14 days after index\n             Myocardial Infarction event\n\n          2. Age < 18 years\n\n          3. Psychologically incapacitated\n\n          4. Patient is pregnant, or is expecting to become pregnant during the course of the\n             trial per Investigator discretion.\n\n          5. Patients contraindicated for NUVANT system\n\n          6. Comorbidities  likely to limit survival to less than the minimal study duration (12\n             months)\n\n          7. Participation in an investigational study with known or suspected cardiac effect\n             expected to confound the results of this study (e.g. stem cell trials, stent trials,\n             cardiac intervention trials, drug trials)\n\n          8. Patients with an existing pacemaker or ICD implanted.\n\n          9. Patients that are dialysis dependent at discharge"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "300", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 21, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01995552", 
            "org_study_id": "Version 1.0 , 07 October 2013", 
            "secondary_id": "REF/2013/10/005823"
        }, 
        "intervention": {
            "arm_group_label": "External Loop Recorder", 
            "intervention_name": "External Loop Recorder", 
            "intervention_type": "Device", 
            "other_name": "NUVANT MCT system (Corventis, Inc., San Jose, CA)"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Post myocardial infarction patients with low EF.", 
        "lastchanged_date": "November 25, 2013", 
        "location": {
            "contact": {
                "email": "balbir.singh@medanta.org", 
                "last_name": "Balbir Singh, DM (Cardiology)", 
                "phone": "0124 441 1441"
            }, 
            "facility": {
                "address": {
                    "city": "Gurgaon", 
                    "country": "India", 
                    "state": "Haryana", 
                    "zip": "122001"
                }, 
                "name": "Medanta - The Medicity"
            }, 
            "investigator": {
                "last_name": "Dr. Balbir Singh, DM (Cardiology)", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "India"
        }, 
        "number_of_arms": "1", 
        "official_title": "IdeNtifying High riSk Patients Post Myocardial Infarction With REduced Left Ventricular Function Using External Loop Recorders (INSPIRE-ELR Study)", 
        "overall_contact": {
            "email": "balbir.singh@medanta.org", 
            "last_name": "Dr. Balbir Singh, DM (Cardiology)", 
            "phone": "0124 441 1441"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "India: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Clinically significant arrhythmias reported by  ELR at acute monitoring period", 
            "safety_issue": "No", 
            "time_frame": "12 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01995552"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "The study is designed to collect the incidence of any post-MI arrhythmias. If an arrhythmia is detected, the patient will be managed per the physician's discretion.", 
            "measure": "Clinically significant arrhythmias reported by  ELR", 
            "safety_issue": "No", 
            "time_frame": "8-10 weeks post MI"
        }, 
        "source": "Medtronic Bakken Research Center", 
        "sponsors": {
            "collaborator": {
                "agency": "Medtronic", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Medtronic Bakken Research Center", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}